Aptargroup

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions and services for the prescription drug, consumer health care, injectables, active packaging, beauty, personal care, home care, and food and beverages. It operates through the following business segments: Beauty & Home, Pharma and Food & Beverage. The Beauty & Home segment primarily sells pumps, aerosol valves and accessories to the personal care and household markets and pumps and decorative components to the fragrance/cosmetic market. The Pharma segment supplies pumps and metered dose inhaler valves to the pharmaceutical market worldwide. The Food & Beverage segment sells dispensing and non-dispensing closures and, to a lesser degree, spray pumps and aerosol valves to the food and beverage markets. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Aptargroup (ATR) reports robust Q4 results and strategic realignment

Aptargroup's Q4 performance reflects strong core sales growth and profitability, driven by the pharma and beauty segments, despite regional challenges.
Realignment initiatives aim to optimize operations and enhance market position, with a focus on cost management and sustainable growth opportunities.
While facing challenges such as volume declines and increased expenses, Aptar remains poised for growth with a positive outlook for the year ahead.
The company's strategic focus on capital efficiencies, innovation, and sustainability underscores its commitment to long-term success and profitability.

Aptar reports solid Q1 growth driven by Pharma and Beauty demand

Aptar's Q1 performance reflects growth in key segments, with a positive outlook for Q2. Strategic focus on operational efficiencies and new product innovations positions the company for continued success.

Aptargroup (ATR) reports solid Q2 performance and optimistic growth outlook

Aptargroup's Q2 2023 performance showcased strength in core sales growth, robust segmental performance, and a focus on sustainability and shareholder value.
While facing challenges in certain operational areas, the company remains optimistic about future growth prospects and is committed to addressing hurdles effectively.
With a positive outlook for Q3 and a strategic focus on innovation and sustainability, Aptar is well-positioned to capitalize on growth opportunities and drive long-term value creation.

Aptargroup reports 2% sales growth in Q3 driven by Pharma success

Aptargroup's Q3 performance reflects solid sales growth and profitability, driven by strength in Pharma and fragrance technologies.
The company's emphasis on innovation, sustainability, and governance underscores its commitment to long-term success and stakeholder value.
Despite challenges in the Beauty segment, Aptar's strategic focus on growth opportunities and cost optimization positions it well for future success.

Aptargroup (ATR) reports solid Q4 earnings, eyes Asia expansion

Aptargroup's Q4 2023 performance reflects steady growth, strong margins, and strategic initiatives for future expansion. While facing challenges in certain segments, the company's focus on innovation and sustainability, along with successful partnerships, positions it well for continued growth. Shareholders benefited from over $104 million returned in 2023.

Aptargroup (ATR) reports robust Q1 results, eyes pharma growth opportunities

Aptargroup's Q1 performance reflects a balanced growth trajectory with strengths in sustainability recognition and product innovation. While challenges in the Beauty segment persist, opportunities in pharma growth and margin improvement are key focus areas for future success.

Aptargroup (ATR) reports solid Q2 results, eyes growth opportunities

Aptargroup's Q2 performance reflects resilience and strategic focus on core business segments amidst market challenges.
The company's financial strength, sustainability recognition, and leadership continuity position it well for future growth.
Challenges in injectables and Beauty segments underscore the need for targeted strategies and market adaptation.
Opportunities lie in innovation, market expansion, and leveraging sustainability efforts for competitive advantage.

Aptar reports robust Q3 performance driven by pharma and food

Aptar's Q3 2024 performance reflects solid core sales growth and increased EPS, driven by strong demand in pharma and food segments. Challenges in the Beauty segment were offset by growth in personal care and home care markets.
Key strengths include operational improvements, acquisitions in the Pharma segment, and recognition for corporate excellence. Aptar's focus on innovation and efficiency presents opportunities for future growth.
While facing challenges in the Beauty segment and CFO transition, Aptar remains optimistic about growth prospects in Pharma and Closures segments, emphasizing innovation and market opportunities.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

The dispensing products company is still comfortable with its position despite weakness in its beauty and home segment.

AptarGroup Leans on Pharma, Food, and Beverage Growth

AptarGroup (ATR) possesses solid growth attributes, which could help it handily outperform the market.

Looking for a Growth Stock? 3 Reasons Why AptarGroup (ATR) is a Solid Choice

AptarGroup (ATR) delivered earnings and revenue surprises of 1.77% and -1.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

AptarGroup (ATR) Q2 Earnings Surpass Estimates

3 Reasons Why Growth Investors Shouldn't Overlook AptarGroup (ATR)

AptarGroup (ATR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why AptarGroup (ATR) Could Beat Earnings Estimates Again

The bullish case for packaging solutions company AptarGroup, Inc. is based on expectations for upside versus consensus, new market opportunities and its exposure to the pharmaceutical sector being "mispriced," according to Morgan Stanley.

3 Reasons Morgan Stanley Is Bullish On AptarGroup

AptarGroup (ATR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

AptarGroup (ATR) Soars to 52-Week High, Time to Cash Out?

AptarGroup (ATR) stock is worth considering now, given its solid prospects and favorable operating backdrop.

Here' Why it is Worth Buying AptarGroup (ATR) Stock Now

Aaron's

AmerisourceBergen

Air Products and Chemicals

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, June 20th.

Top Ranked Momentum Stocks to Buy for June 20th

Casella Waste Systems

John Bean Technologies

Roper Technologies

We suggest four industrial stocks that are near their 52-week highs and have the potential to gain further on the healthy prospects of the industrial products sector.

4 Industrial Stocks Near 52-Week High With More Room to Run

AptarGroup (ATR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

AptarGroup (ATR) Upgraded to Strong Buy: Here's What You Should Know

The acquisitions of Nanopharm and Gateway Analytical aid AptarGroup's (ATR) pharma to support customers' complex drug formulations and delivery requirements.

AptarGroup Acquires 2 Companies to Expand Pharma Services

DXP Enterprises

H&E Equipment Services

Terex

Timken

Manufacturing activity dipped in May on heightened concerns about a trade war.

5 Industrial Stocks to Bet on Despite Trade War Jitters

Does AptarGroup (ATR) have what it takes to be a top stock pick for momentum investors? Let's find out.

Are You Looking for a Top Momentum Pick? Why AptarGroup (ATR) is a Great Choice

AptarGroup (ATR) Hits 52-Week High, Can the Run Continue?

AptarGroup (ATR) reported earnings 30 days ago. What's next for the stock?

AptarGroup (ATR) Down 0.1% Since Last Earnings Report: Can It Rebound?

Business-transformation plan and bright earnings prospects make AptarGroup (ATR) an attractive investment option.

Reasons to Add AptarGroup Stock to Your Portfolio Right Now

AptarGroup's (ATR) business-transformation plan will help drive the top line, boost operational excellence, enhance approach to innovation and improve organizational effectiveness.

AptarGroup Bets on Transformation Plan, Innovative Products

AptarGroup (ATR) could produce exceptional returns because of its solid growth attributes.

AptarGroup (ATR) is an Incredible Growth Stock: 3 Reasons Why

Take a closer look at its latest quarter to find out.

Is AptarGroup Worth Buying Near All-Time Highs?

AptarGroup Hits 52-Week High

AptarGroup (ATR) is well positioned to outperform the market, as it exhibits above-average growth in financials.

AptarGroup: An Incredible Growth Stock

AptarGroup Inc.'s (ATR) CEO Stephan Tanda on Q1 2019 Results - Earnings Call Transcript

AptarGroup (ATR) achieves year-over-year solid core sales growth across all segments in first-quarter 2019.

News for Aptargroup Stock (ATR)